The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Acid Reducer Maximum Strength
Famotidine 20mg · FAMOTIDINE 20 mg/1 · Tablet · Oral · Grocery Outlet
NDC 85828-0443-25 · 1 BOTTLE in 1 CARTON / 25 TABLET in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- ANDA215822
- TE code
- —
- Approval date
- Jan 28, 2022
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Famotidine 20mg (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Cabinet Health P.B.C. | FAMOTIDINE 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Grocery Outlet | FAMOTIDINE 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| YYBA Corp | FAMOTIDINE 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Acid Reducer Maximum Strength — NDC 85828-0443-25," retrieved September 3, 2026, https://drugdashboards.com/drug/85828044325.
Free to cite with attribution — see how the data is put together.